Dashboard
1
With ROE of 36.03%, it has a Very Expensive valuation with a 7.69 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 37.82%, its profits have risen by 7.6% ; the PEG ratio of the company is 2.8
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
69.71%
0%
69.71%
6 Months
80.0%
0%
80.0%
1 Year
116.0%
0%
116.0%
2 Years
233.71%
0%
233.71%
3 Years
171.23%
0%
171.23%
4 Years
296.0%
0%
296.0%
5 Years
525.26%
0%
525.26%
Clínica Baviera SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
20.27%
EBIT Growth (5y)
24.71%
EBIT to Interest (avg)
40.48
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
2.41
Tax Ratio
27.22%
Dividend Payout Ratio
48.42%
Pledged Shares
0
Institutional Holding
0.12%
ROCE (avg)
93.51%
ROE (avg)
40.00%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
7.69
EV to EBIT
14.52
EV to EBITDA
10.35
EV to Capital Employed
13.44
EV to Sales
2.91
PEG Ratio
2.80
Dividend Yield
2.68%
ROCE (Latest)
92.58%
ROE (Latest)
36.03%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Mar 2010
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
87.00
80.20
8.48%
Operating Profit (PBDIT) excl Other Income
26.40
24.10
9.54%
Interest
0.00
0.30
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.70
12.90
13.95%
Operating Profit Margin (Excl OI)
226.90%
229.30%
-0.24%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 8.48% vs 20.78% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 13.95% vs 4.03% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
301.80
262.60
14.93%
Operating Profit (PBDIT) excl Other Income
106.10
92.80
14.33%
Interest
2.30
1.20
91.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
42.90
41.10
4.38%
Operating Profit Margin (Excl OI)
272.50%
273.90%
-0.14%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 14.93% vs 16.76% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 4.38% vs 11.99% in Dec 2024
About Clínica Baviera SA 
Clínica Baviera SA
Hospital
No Details Available.
Company Coordinates 
No Company Details Available






